We previously proposed that the adjacent dnrIJ genes represent a two-component regulatory system controlling daunorubicin biosynthesis in Streptomyces peucetius on the basis of the homology of the DnrI and DnrJ proteins to other response regulator proteins and the effect of a dnrI::aphII mutation. In the present paper we report the results of work with the dnrI::aphII mutant in complementation, bioconversion, and transcriptional analysis experiments to understand the function of dnrI. For five putative operons in the sequenced portion of the S. peucetius daunorubicin biosynthesis gene cluster examined, all of the potential transcripts are present in the ⌬dnrJ mutant and wild-type strains but absent in the dnrI::aphII strain. Since these transcripts code for both early-and late-acting enzymes in daunorubicin biosynthesis, dnrI seems to control all of the daunorubicin biosynthesis genes directly or indirectly. Transcriptional mapping of the 5 and 3 ends of the dnrIJ transcript and the termination site of the convergently transcribed dnrZUV transcript reveals, interestingly, that the two transcripts share extensive complementarity in the regions coding for daunorubicin biosynthesis enzymes. In addition, dnrI may regulate the expression of the drrAB and drrC daunorubicin resistance genes. The ⌬dnrJ mutant accumulates -rhodomycinone, the aglycone precursor of daunorubicin. Since this mutant contains transcripts coding for several early-and late-acting enzymes and since dnr mutants blocked in deoxysugar biosynthesis accumulate -rhodomycinone, we conclude that dnrJ is a daunosamine biosynthesis gene. Moreover, newly available gene sequence data show that the DnrJ protein resembles a group of putative aminotransferase enzymes, suggesting that the role of dnrJ is to add an amino group to an intermediate of daunosamine biosynthesis.
Actinomycetes have a complex life cycle that includes both morphological (sporulation) and physiological (antibiotic production) differentiation, and they have developed an impressive array of regulatory mechanisms to control these processes. While the mode of action of genes that control the formation of aerial mycelia and sporulation is becoming clearer (4) , a detailed molecular model for the control of antibiotic production still is lacking. Since antibiotic biosynthesis is thought to be under the control of a cascade of events that respond to several environmental factors and sometimes is coordinately regulated with sporulation, investigation of the regulation of antibiotic production will provide knowledge that could serve as an useful paradigm to understand other complex regulatory processes in the actinomycetes. Furthermore, such information is of great value in manipulating these industrially important microorganisms to improve antibiotic production, as has been demonstrated in the case of daunorubicin (DNR) production in Streptomyces peucetius (25, 34, 35) .
The existence of a regulatory hierarchy for both sporulation and antibiotic production has been known for some time. At one level both sporulation and antibiotic production are governed by common genes, known as bld genes, that control both aerial mycelium formation and antibiotic production. The beststudied example of this class of genes is bldA, whose product is a tRNA for a rare leucine codon, UUA (21) . This rare codon is present in the Streptomyces coelicolor actII-ORF4 gene, whose product is a transcriptional activator of the actinorhodin biosynthesis genes (9) . At the second level, there are genes that regulate the biosyntheses of two or more antibiotics in the same organism and yet have no effect on sporulation. In S. coelicolor, genes such as absA (2) , absB (1), abaA (10) , and afsR (18) control or influence the biosyntheses of two or more antibiotics, namely, actinorhodin, undecylprodigiosin, methylenomycin, and the calcium-dependent antibiotic. In contrast, a large class of genes known as whi genes control only sporulation (4) . At the third level, individual antibiotic biosynthesis pathways are controlled by regulatory genes that are directly linked to the biosynthesis gene cluster. For example, S. coelicolor actII-ORF4 (9) and redD-ORF1 (22) and Streptomyces hygroscopicus brpA (3) act as transcriptional activators of the actinorhodin, undecylprodigiosin, and bialaphos biosynthesis genes, respectively.
We have previously suggested that two loci, dnrR 1 and dnrR 2 , control DNR biosynthesis in S. peucetius (35) . Their introduction into the wild-type strain on a high-copy-number plasmid stimulates the production of DNR as well as that of an early intermediate in DNR production, ε-rhodomycinone (RHO) (35) . Two genes, dnrI and dnrJ, were identified by sequence analysis of the dnrR 1 locus. While the deduced DnrI protein is homologous to the products of other bonafide regulatory genes, such as S. coelicolor actII-ORF4 (9), redD-ORF1 (22) , and afsR (18) , that regulate or influence antibiotic biosynthesis, the deduced DnrJ protein is similar to the products of Streptomyces antibiotic biosynthesis genes such as eryC1 (7) and strS (8) and to the Bacillus stearothermophilus degT gene product (36) . Since the loss of degT function has a pleiotropic phenotype (36) and since the deduced DnrI and DnrJ proteins share some characteristic features with other sensor kinase and response regulator proteins, suggesting that they could be regulatory genes (31, 35) , we proposed that dnrI and dnrJ represent a two-component regulatory system controlling DNR biosynthesis (35) . We now provide evidence in support of a role for dnrI in transcriptional activation of most if not all of the DNR biosynthesis genes. Contrary to our earlier hypothesis (35) , dnrJ now appears not to be a regulatory gene: on the basis of the strong similarity of the deduced DnrJ protein to other newly characterized sugar biosynthesis enzymes, dnrJ as well as its numerous homologs from other sets of antibiotic biosynthesis genes is likely to encode enzymes for the addition of an amino group in the biosynthesis of certain deoxyaminosugars (37) .
MATERIALS AND METHODS
Bacterial strains and plasmids. Escherichia coli DH5␣ and JM105 (28) were used for routine subcloning and preparation of single-stranded DNA. S. peucetius ATCC 29050 was obtained from the American Type Culture Collection (Rockville, Md.). RHO, carminomycin (CAR), and DNR were obtained from Farmitalia Carlo Erba, Milan, Italy. The vectors used in this study were pIJ702 (19) , pWHM601 (14) , pDH5 (15) , and M13 phage-derived mp18 and mp19 (40) .
Media and growth conditions. S. peucetius was maintained on ISP4 medium (Difco Laboratories, Detroit, Mich.) for the preparation of spores, and liquid R2YE medium (17) was used for the propagation of mycelium as a seed inoculum. Transformants of S. peucetius in which the introduced single-stranded version of recombinant pDH5 DNA had integrated into the dnrJ gene were selected on 25 g of thiostrepton (obtained from S. J. Lucania, E. R. Squibb & Sons, Princeton, N.J.) per ml. S. peucetius transformed with pWHM601 and its derivatives were selected on 25 g of apramycin (obtained from Eli Lilly and Company, Indianapolis, Ind.) per ml. E. coli strains were grown in LB medium (28) , and when transformants were selected, ampicillin or apramycin was added at a concentration of 100 g/ml. Two-times YT medium (28) was used to grow M13-containing hosts to prepare single-stranded DNA for sequencing.
Disruption of dnrJ. A 0.5-kb BglII-SphI fragment inside dnrJ from the 3.8-kb BamHI dnrR 1 segment (35) was removed by complete digestion of the 3.8-kb segment with BglII followed by partial digestion with SphI (there are three SphI sites). A 72-bp BamHI-SphI linker from the polylinker region of pGEM7Zf(ϩ) (Promega, Madison, Wis.) was inserted in the BglII and SphI sites, thereby deleting 493 bp of dnrJ and resulting in an in-frame dnrJ mutation. The 3.3-kb BamHI segment containing the ⌬dnrJ gene was cloned into the integrating vector pDH5 (14) , which does not have a Streptomyces origin of replication and consequently can be maintained only if it integrates into the genome by homologous recombination. The single-stranded version of the resulting recombinant vector was made by using the helper phage M13KO7 (38) by standard protocols (28) . The single-stranded DNA containing the ⌬dnrJ gene was introduced into S. peucetius protoplasts by transformation by standard techniques (17) , and the transformants (with their genomes disrupted by the integrated plasmid) were selected with 25 g of thiostrepton per ml. Strains in which the resident wild-type copy of dnrJ was replaced by the mutated copy were obtained from these transformants by the following protocol. Protoplasts were prepared from the disrupted strain and regenerated, and then the regenerated cells were grown in liquid R2YE medium and plated on ISP4 agar to obtain spores. Colonies obtained from individual spores were screened on ISP4 agar to obtain thiostreptonsensitive strains. Of several such strains obtained, only one had the desirable genotype in which the wild-type copy of dnrJ is replaced by the mutated copy. Southern analysis (28) of the genomic DNA from the ⌬dnrJ mutant showed that the 0.5-kb BglII-SphI fragment of the wild-type dnrJ gene is missing and has been replaced by the deleted copy (data not shown). This ⌬dnrJ strain was designated WMH1524.
Isolation and manipulation of DNA and RNA. DNA isolation, restriction endonuclease digestions, and ligations were performed according to standard techniques (28) with materials purchased from United States Biochemicals, Cleveland, Ohio, and Bethesda Research Laboratories, Gaithersburg, Md. DNA labelled with the United States Biochemicals random primer extension kit or the Boerhinger Mannheim (Indianapolis, Ind.) Genius nonradioactive DNA labelling kit was hybridized to DNA immobilized on Hybond N membranes (Amersham, Chicago, Ill.) according to standard techniques (28) . DNA fragments for labelling and subcloning were isolated from an agarose gel by using either a GENECLEAN kit (Bio 101, Inc., La Jolla, Calif.) or an NA45 DEAE membrane (Schleicher and Schuell, Keene, N.H.) according to the manufacturer's protocols. The method of Fisher and Wray (11) was used for the isolation of RNA, except that the cells were lysed with a mortar and pestle in the presence of liquid nitrogen followed by the addition of lysis buffer.
DNA sequencing. DNA fragments subcloned in M13 vectors were sequenced with the United States Biochemicals Sequenase version 2.0 sequencing kit according to the manufacturer's suggestions. 7-Deaza-dGTP was used instead of dGTP to avoid compressions.
RNA analyses. Low-resolution S1 nuclease protection experiments were performed with standard conditions for hybridization and S1 digestion (28) . Primer extension analysis was performed by the method of Stein et al. (30) with modifications described elsewhere (14) . Eighteen-mer (5Ј-CAACATATTGATCTG-CAT-3Ј) and 30-mer (5Ј-CGCGTCAGCAGGTGGCATATTTCCGGCGGC-3Ј) oligodeoxynucleotide primers complementary to sequences 92 nucleotides (nt) and 31 nt downstream of the transcription start site of dnrIJ mRNA, respectively, were synthesized and used in primer extension analysis. These two primers were annealed to the M13mp18 single-stranded template containing a 0.66-kb BamHI-SphI DNA fragment, and a sequencing reaction was performed to provide size standards to identify the start site of the dnrIJ transcript.
Bioconversion of RHO and CAR to DNR. S. peucetius ⌬dnrJ and dnrI::aphII mutants (35) and their transformants harboring different plasmids were inoculated into liquid R2YE medium. After 2 days of growth at 30ЊC, 2.5 ml of this culture was transferred to 25 ml of the GPS DNR production medium (5) . When necessary, 25 g of apramycin per ml was added to maintain the plasmid. Cultures then were grown at 30ЊC for 24 or 72 h, after which RHO or CAR, respectively, was added to a final concentration of 5 g/ml. The cultures were further incubated for a total period of 96 h, after which they were analyzed chromatographically for the presence of DNR by previously published protocols (25) . DNR production was detectable by 72 h under these conditions.
RESULTS
Effect of disruption of the dnrJ gene. The phenotype of the dnrI::aphII strain and the subtle similarities between the deduced DnrI and DnrJ proteins and members of two-component regulatory systems prompted us to propose in an earlier paper (35) that dnrI and dnrJ represent a two-component regulatory system controlling DNR production. To test this idea, we made an in-frame mutation in the dnrJ gene alone to see if the ⌬dnrJ mutant had the properties expected of a strain with a mutation in a regulatory gene. The ⌬dnrJ mutant WMH1524, obtained by the strategy outlined in Materials and Methods, accumulates RHO when grown in a DNR production medium (5) for 4 days. To test whether the accumulation of RHO is due to loss of dnrJ function alone, the wild-type dnrJ gene was introduced back into the ⌬dnrJ mutant to see if DNR production was restored. A 1.2-kb RsrII fragment containing dnrJ was cloned into the SmaI site of pUC19 after filling in of the RsrII sticky ends to obtain plasmid pWHM907. The dnrJ gene in pWHM907 then was transferred to a low-copy-number plasmid, pWHM601, under the control of the mel promoter (from plasmid pIJ702 [19] ), to yield plasmid pWHM908. When pWHM908 was introduced into the WMH1524 strain, the transformants produced DNR as determined by chromatographic analysis, indicating that the mutation in the disrupted strain affects only dnrJ.
Analysis of the function of the dnrJ gene. The anthracyclinone RHO and the 2,3,6-trideoxyamino sugar daunosamine are synthesized separately, and then daunosamine is attached to RHO by a glycosyltransferase before late-acting enzymes can continue DNR biosynthesis (reviewed in reference 33). Therefore, the accumulation of RHO by the ⌬dnrJ mutant suggests that dnrJ either regulates late steps in DNR biosynthesis following the formation of RHO or encodes an enzyme for daunosamine biosynthesis. To distinguish between these two possibilities, several complementation and bioconversion experiments were performed. pWHM908 was introduced into the dnrI::aphII strain, and the transformants were tested for their ability to bioconvert RHO and CAR to DNR in the DNR production medium. According to chromatographic analyses (not shown), the dnrI::aphII strain containing dnrJ does not bioconvert RHO or CAR to DNR, but the ⌬dnrJ mutant is able to convert added CAR to DNR, the last step in DNR biosynthesis. This suggests that dnrJ does not regulate all of the late steps in DNR biosynthesis starting from RHO, if in fact it regulates any of them.
Comparison of the deduced DnrJ protein sequence with recently available protein sequences by FASTA, TFASTA, and COMPARE/DOTPLOT analyses (6) has revealed a high degree of sequence similarity among DnrJ, the deduced product of the Salmonella rfb orf10.4 gene (rfbH) (26) , and the CDP-6-dideoxy-L-threo-D-glycero-4-hexulose-3-dehydrase (E1) pro- -glucoseen reductase (E3) catalyzes C-3 deoxygenation in the biosynthesis of the deoxysugar CDP-ascarylose (39) . These and other data have been used to argue that DnrJ, as a member of a set of five closely similar proteins, catalyzes the introduction of an amino group during the biosynthesis of various deoxyaminosugars found in antibiotics (37) .
Analysis of the function of the dnrI gene. The disruption of dnrI results in the absence of RHO and DNR production, and we have suggested that dnrI controls DNR biosynthesis (35) , largely on the basis of the strong similarity of the DnrI and actII-OrF4 proteins. Since the DnrJ protein now appears to be involved in deoxyaminosugar biosynthesis and should be lacking in the dnrI::aphII strain because of polarity of the dnrI::aphII mutation, we had assumed that the introduction of dnrI into the dnrI::aphII strain should permit RHO to be produced. Previously, we reported that the introduction of dnrI on a high-copy-number vector has a deleterious effect on the growth of the dnrI::aphII strain (35). Since we could not determine if RHO was produced in this experiment, we tested whether the introduction of dnrI into the dnrI::aphII strain on the low-copy-number vector pWHM601 (as pWHM909) would permit the transformants to accumulate RHO. The strain transformed with pWHM909 grew normally and was able to accumulate very small but detectable quantities of RHO. Since we also found that the dnrI::aphII strain does not bioconvert CAR to DNR, it appears that dnrI controls not only early steps (RHO formation) but also the terminal step in DNR biosynthesis.
To gain support for the idea that dnrI may regulate other dnr genes transcriptionally, we analyzed the dnrI::aphII strain, the ⌬dnrJ mutant, and the wild-type strain for the presence or absence of transcripts coding for different enzymes in DNR biosynthesis. An additional aim of this experiment was to learn whether dnrJ is a regulatory gene or a structural gene for daunosamine biosynthesis. On the basis of DNA sequence and limited mutational analyses of the dnr gene cluster (13, 24, 35) , five potential polycistronic transcripts have been identified that contain either putative daunosamine biosynthesis genes (dnrL, dnrQ, dnrU, and dnrX), polyketide synthase genes (dpsA and dpsB), or late-acting genes (dnrK and dnrP) (Fig. 1) . A representative gene from each transcriptional unit was tested by low-resolution S1 nuclease protection experiments to see whether it is expressed in the three strains ( Fig. 2 ; data for only three transcripts are shown for convenience). The portions tested in all five of these transcripts were present in the ⌬dnrJ mutant and wild-type strains but absent in the dnrI::aphII strain, suggesting that dnrI is a transcriptional regulation gene while dnrJ is not (Fig. 2) .
Analysis of the function of dnrN. In addition to dnrR 1 , there is an additional locus, dnrR 2 , that also regulates DNR biosynthesis (35) . This locus contains the dnrN gene (23), whose product shows a strong similarity to the response regulator protein UhpA (12) and several other response regulators in the same subclass (31) . Disruption of dnrN abolishes DNR biosynthesis completely (23) , and thus the dnrN::aphII strain is phenotypically similar to the dnrI::aphII strain. To test whether dnrI is regulated by dnrN, we analyzed mRNA isolated from a dnrN::aphII strain for the presence of the dnrIJ transcript by low-resolution S1 nuclease protection analysis. The dnrIJ transcript was present in the wild-type strain but not in the   FIG. 1 . Physical map of the cluster of dnr genes in S. peucetius ATCC 29050. The thick line shows the BamHI (B), BglII (Bg), and EcoRI (E) sites in the genomic DNA characterized to date. The two BamHI segments that contain the dnrR 1 and dnrR 2 segments discussed in the text are indicated. The dnr genes are designated by letters or arabic numerals, and selected genes are shaded to indicate the function, designated below the map, which was deduced from the results of sequence analysis, gene disruption, and/or expression experiments (13, 24) (dps, DNR polyketide synthase, cyclase, and reductase genes). The dnrXYZUV genes are homologs of the Streptomyces griseus lkm genes described by Krügel et al. (20) . The wavy arrows indicate transcripts that have been mapped by S1 nuclease protection and primer extension experiments.
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on June 21, 2017 by guest http://jb.asm.org/ dnrN::aphII strain ( Fig. 3A; the size of the protected fragment is 548 bp), indicating that the expression of dnrI is under the control of dnrN. Analysis of the control of DNR resistance. Since the dnrI::aphII and dnrN::aphII strains are sensitive to DNR compared with the wild-type strain (23, 35), we analyzed mRNAs from the wild-type, dnrI::aphII, and dnrN::aphII strains for the presence of transcripts coding for the putative DNR resistance proteins DrrA (14) , DrrB (14) , and DrrC (16) by low-resolution S1 nuclease protection analysis to clarify the roles of dnrI and dnrN in regulating DNR resistance in S. peucetius. Both the drrAB and drrC transcripts were missing in the dnrI::aphII and dnrN::aphII strains but were present in the wild-type strain ( Fig. 3B and C; the sizes of the protected fragments are 513 and 883 bp for the drrC and drrAB transcripts, respectively), which suggests that dnrI is the actual regulator of DNR resistance and that dnrN exerts its influence indirectly through dnrI. The alternative explanation for the absence of the drrAB and drrC transcripts, that expression of drrAB and drrC is induced by DNR, is not ruled out by these data, but induction of a drrC::xylE transcriptional fusion by DNR was not observed in other work (16) .
Analysis of the start site and size of the transcript coding for DnrI and DnrJ. The apparent polarity of the dnrI::aphII mutation led us to suspect that the dnrIJ genes are transcribed as at least a bicistronic message. To examine this possibility, a 0.66-kb BamHI-SphI fragment containing a portion of dnrI and some upstream sequence (Fig. 4) was used in a low-resolution S1 nuclease protection experiment to locate approximately the 5Ј end of the putative dnrIJ transcript. A 0.56-to 0.57-kb fragment was protected (Fig. 5A) , indicating that the dnrIJ transcript starts approximately 90 to 100 bases upstream of dnrI. This portion of the transcript was present in cultures harvested 24, 48 , and 72 h after inoculation (Fig. 5A) , consis-500 bp
Low-resolution S1 nuclease protection analysis to determine the targets of dnrI regulation. DNA fragments corresponding to sequences internal to the dpsAB (A), dnrLM (B), and dnrZUV (C) transcripts were cloned in the appropriate orientation in M13 vectors. The single-stranded DNA versions of these fragments were hybridized overnight at 50ЊC with mRNAs (40 g) from different strains and then digested with 150 U of S1 nuclease. Reaction mixtures were resolved on a 4% denaturing polyacrylamide gel and blot transferred to a Hybond N membrane, and the membranes were probed with appropriate labelled DNAs. Low-resolution S1 nuclease protection analysis to determine the expression of the dnrIJ, drrAB, and drrC transcripts in dnrI::aphII, dnrN::aphII, and wild-type strains. DNA fragments corresponding to sequences internal to the dnrIJ (A), drrAB (B), and drrC (C) transcripts were cloned in the appropriate orientation in M13 vectors. The single-stranded DNA versions of these fragments were hybridized overnight at 50ЊC with mRNAs (40 g) from different strains and then digested with 150 U of S1 nuclease. Reaction mixtures were resolved on a 4% denaturing polyacrylamide gel and blot transferred to a Hybond N membrane, and the membranes were probed with appropriate labelled DNAs.
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on June 21, 2017 by guest http://jb.asm.org/ tent with the appearance of antibiotic production at 24 h by chromatographic analysis of culture supernatants. On the basis of these results, two oligodeoxynucleotides were synthesized and used in primer extension analysis. The results ( Fig. 6A and B) suggest that the apparent transcript start site is located at the A 92 nt upstream of the predicted translational start site of DnrI (35) . The minor signal seen in Fig. 6A and B when the 18-mer primer was used corresponds to the G 75 nt upstream of the predicted DnrI translation start site (35) and is believed to be an artifact due to the presence of an inverted repeat sequence upstream of this base that could result in the premature termination of transcription by reverse transcriptase. Since the major signal in Fig. 6A and B was present when either of the two different primers was used, we believe that the true transcriptional start site is 92 nt upstream of the predicted DnrI translation start site. Comparison of the DNA sequence upstream of this transcriptional start site with a limited number of Streptomyces promoter regions (32) indicates that the transcriptional start site is preceded by Ϫ10 and Ϫ35 regions that resemble analogous regions in the vegetative promoters of some Streptomyces genes (32) (Fig. 6C) .
To estimate the size of the dnrIJ transcript, 0.9-kb SphI, 0.49-kb SphI-BglII, 1.06-kb BglII-SphI, and 0.6-kb SphI-BamHI fragments from the 3.8-kb BamHI segment (Fig. 4) were used in low-resolution S1 nuclease protection experiments. When single-stranded DNAs complementary to the dnrIJ transcript were used, all four of these DNA fragments were fully protected (Fig. 5B) . The dnrJ open reading frame extends approximately 100 bp into the 1.06-kb BglII-SphI fragment d, but transcription further downstream is in the antisense orientation with respect to the dnrV and dnrU genes. The 0.49-kb SphI-BglII, the 1.06-kb BglII-SphI, and the 0.6-kb SphI-BamHI fragments c, d, and e, respectively, were also fully protected when tested in the orientation opposite to that of dnrIJ transcription (Fig. 5C) ; approximately 0.5 kb of the 0.9-kb SphI fragment b was also protected (Fig. 5C ). (The smear observed with the 1.06-kb BglII-SphI fragment was highly reproducible and may be due to excessive digestion of the DNA-RNA hybrid by S1 nuclease. Extensive degradation of the 3Ј end of the putative dnrZUV message in vivo seems a less likely explanation, since the mRNA further towards the putative 3Ј end and protected by the 0.49-kb fragment was not degraded.) These results indicate that transcription initiating upstream of dnrU creates an mRNA that is partly complementary to dnrJ mRNA. The end of the dnrZUV transcript appears to be located approximately at the end of the dnrI open reading frame. Thus, the two transcripts have extensive complementarity in the region that is presumed to code for sugar biosynthesis enzymes (Fig. 1) (20) .
DISCUSSION
As a first step in an effort to understand the factors that regulate antibiotic biosynthesis, we have started analyzing the regulation of DNR biosynthesis in S. peucetius by genes that are directly linked to the DNR structural and self-resistance genes. Our previous results suggested that the dnrR 1 locus is involved in the regulation of DNR biosynthesis in S. peucetius and led to the proposition that the two genes, dnrI and dnrJ, in this locus act as a two-component regulatory system. To test this hypothesis, we made an in-frame deletion mutation in dnrJ to find out if it indeed is a regulatory gene. We also analyzed the dnrI::aphII mutant obtained in our previous study (35) by complementation, bioconversion, and transcript analysis experiments to understand the mode of action of dnrI in regulating DNR biosynthesis.
We have sequenced a large portion of the DNR biosynthesis gene cluster and tentatively assigned a function to several of the dnr genes on the basis of the similarity of their deduced proteins to enzymes with established functions in other metabolic pathways and the results of selected gene disruption or expression experiments (13, 24) . The dnr genes analyzed to date can be tentatively grouped into at least five operons from the results of this work (Fig. 1) . Representative portions of all of these five potential transcripts are present in the ⌬dnrJ mutant and wild-type strains but are absent in the dnrI::aphII strain. Since the genes for these transcripts code for early-as well as late-acting enzymes in DNR biosynthesis, our present results suggest that dnrI controls all of the DNR biosynthesis pathway genes directly or indirectly at the level of transcription. In addition, dnrI seems to regulate the expression of genes that govern DNR resistance in this strain. The global role of dnrI is confirmed by observing that RHO production is restored when dnrI is cloned on a low-copy-number plasmid in the dnrI::aphII background. As expected, DNR is not also produced because of the polarity of the mutation on dnrJ, a gene required for a post-RHO step in DNR biosynthesis.
We have known for some time that there is an additional locus, dnrR 2 , that also controls DNR biosynthesis (35) , and an open reading frame that codes for a response regulator-like protein, DnrN, recently has been identified in this locus (23) . Even though the deduced DnrN protein resembles the response regulator protein UhpA (12), a gene coding for a cognate histidine kinase-like sensor protein has not yet been identified in the dnr gene cluster. The absence of the dnrIJ transcript in the dnrN::aphII strain suggests that DnrN acts as a positive activator for the transcription of dnrI, but we do not know whether DnrN requires an additional sensor protein for its activity in activating transcription of dnrI. The possibility that some intermediates in the pathway have a feedback regulatory effect on some or all steps in DNR biosynthesis also cannot be ruled out. However, our results suggest that dnrI, whose deduced product is homologous to those of other Streptomyces regulatory genes, such as actII-ORF4 (9), redD-ORF1 Fig. 4 . mRNA (40 g) was hybridized overnight at 50ЊC with the DNA fragment and then digested with 150 U of S1 nuclease, and the reaction mixture was resolved on a 4% denaturing polyacrylamide gel and blot transferred to a Hybond N membrane. The membrane was probed with the labelled 3.8-kb BamHI DNA fragment shown in Fig. 4 . The locations of molecular weight standards are indicated by thin lines. (B) Low-resolution S1 nuclease protection analysis of dnrIJ mRNA from a 24-h culture with the appropriate single-stranded 0.9-kb SphI, 0.49-kb SphI-BglII, 1.06-kb BglII-SphI, and 0.6-kb SphI-BamHI DNA fragments. (C) Low-resolution S1 nuclease protection analysis of dnrZUV mRNA from a 24-h culture with the appropriate single-stranded 0.9-kb SphI, 0.49-kb SphI-BglII, 1.06-kb BglII-SphI, and 0.6-kb SphI-BamHI DNA fragments. The locations of the undigested fragments used in S1 nuclease protection analyses and other lower molecular weight markers are indicated by thin lines. The lane labelled molecular weight standards has been electronically modified to remove smears between individual fragments.
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STREPTOMYCES PEUCETIUS dnrIJ GENES 1213 (22) , and afsR (18) , acts as the activator of transcription of most if not all of the DNR structural and resistance genes. A similar mechanism of transcriptional activation exists in actinorhodin biosynthesis, in which actII-ORF4 has been shown to be necessary for transcription of several actinorhodin biosynthesis genes (9) . Contrary to our initial hypothesis that dnrI and dnrJ act as a two-component regulatory system in regulating DNR biosynthesis, the finding that a ⌬dnrJ mutant accumulates RHO shows that dnrJ is not likely to control early steps in DNR biosynthesis leading to the formation of RHO. The presence in the ⌬dnrJ mutant of the five different transcripts examined that encompass a major portion of the dnr genes strongly suggests that dnrJ encodes an enzyme rather than a transcriptional regulator. Otherwise, its inactivation would most likely have abolished the transcription of one or more of the dnrL, dnrQ, dnrX, dnrU, and dpsAB genes. The ability of the ⌬dnrJ mutant to bioconvert CAR to DNR, a late enzymatic reaction, provides further evidence that dnrJ is not likely to be a regulatory gene. Since the sugar moiety has to be synthesized and attached to RHO before late-acting enzymes can continue DNR biosynthesis, mutants blocked in sugar biosynthesis accumulate RHO. Thus, dnrJ seems to be a daunosamine biosynthesis gene, and as discussed elsewhere (37) , the DnrJ protein resembles a group of putative aminotransferase enzymes for antibiotic biosynthesis in other bacteria. We thus believe that the role of DnrJ is to add an amino group to an intermediate of daunosamine biosynthesis, using a pyridoxamine cofactor. FIG. 6 . Determination of the start point of the dnrIJ transcript by using two different oligodeoxynucleotide primers, an 18-mer (A) and a 30-mer (B). mRNA (40 g ) from a 24-h culture of S. peucetius was annealed to primer and extended with MLV reverse transcriptase. The products of the reaction were resolved on a denaturing 6% polyacrylamide gel. Lane 1, product of the primer extension reaction; lanes T, C, G, and A, dideoxy sequencing ladder generated from the 0.66-kb BamHI-SphI DNA fragment with the same primers. The sequence of a portion of the complementary strand is shown. The asterisk in the portion of the sequence shown indicates the apparent transcription start site. (C) Comparison of the dnrIJ promoter region with the Streptomyces consensus promoter sequence. Sequences are aligned with the transcription start site at the right. Highly conserved nucleotides in the Ϫ10 and Ϫ35 regions of Streptomyces promoters are indicated by capital letters, and the less highly conserved nucleotides are indicated by lowercase letters (32) . The hexanucleotide sequences in the putative Ϫ10 and Ϫ35 regions are underlined.
It is surprising that the dnrIJ transcript is at least 3.6 kb and extends approximately 1.6 kb beyond the 3Ј end of the dnrJ gene. The dnrIJ transcript and the convergently transcribed dnrZUV transcript share significant complementarity in the region coding for putative sugar biosynthesis enzymes, as depicted in Fig. 4 by a wavy line. Since RHO and DNR are produced in an approximately 10:1 ratio in strain ATCC 29050 (33) , sugar biosynthesis seems to be a limiting step in DNR biosynthesis, and thus we wonder if S. peucetius regulates daunosamine biosynthesis as well as DNR biosynthesis by synthesizing complementary (antisense) mRNA in dnrIJ/dnrZUV region. This is an intriguing idea to examine further, since it is well precedented in other bacteria (29) and is thought to be a mechanism regulating actinorhodin production in Streptomyces lividans upon its transformation with a 476-bp noncoding DNA fragment cloned from Streptomyces fradiae (27) .
